# Contipro a.s. – FDA Inspection, May 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/contipro-as/95e43348-ae0f-4dec-bebc-db7834424e1a
Source feed: FDA_Inspections

> FDA inspection 1058965 of Contipro a.s., May 25, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058965
- Company Name: Contipro a.s.
- Inspection Date: 2018-05-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1271552 - 2024-02-15
- FDA Inspection 805846 - 2012-10-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/john-p-mistler/7b2d423d-46cc-48bd-aa5a-4ae794888060)

Company: https://www.keypedia.com/companies/contipro-as/db85d0e1-6272-40fe-9a2b-2491541163f1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c